Nucleoside/Nucleotide Analogues for the Treatment of Chronic Hepatitis B: A 3-Year Follow Up Study

Nucleoside/Nucleotide Analogues for the Treatment of Chronic Hepatitis B: A 3-Year Follow Up Study

Introduction. Chronic hepatitis B (CHB) is endemic in Indonesia, where it is usually treated with pegylated interferon and nucleoside/nucleotide analogs (NA). The aim of this study was to determine the efficacy of treating CHB infection among Indonesian patients with NA (lamivudine, telbivudine, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Andri Sanityoso Sulaiman, Irsan Hasan, Cosmas Rinaldi A. Lesmana, Chyntia Olivia M. Jasirwan, Saut Horas H. Nababan, Kemal Fariz Kalista, Gita Aprilicia, Rino Alvani Gani
Format: Article
Language:Indonesian
Published: Department of Internal Medicine, Faculty of Medicine Universitas Indonesia 2021-09-01
Series:Jurnal Penyakit Dalam Indonesia
Subjects:
3-years follow up study
chronic hepatitis b
nucleoside/nucleotide analogue
Online Access:http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/598/284
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/598/284

Similar Items